Only recently, mutations in SAMHD1 were also detected in 7.1% (13/182) of mantle cell lymphoma (MCL) patients selected from the MCL Younger and Elderly trials; of note, both cohorts only included previously untreated patients [23]. Here, SAMHD1 is linked to mantle cell lymphoma.